| 000 | 00982nam a2200277 a 4500 | ||
|---|---|---|---|
| 005 | 20250914125124.0 | ||
| 008 | 021105s2002 xxua b 001 0 eng b | ||
| 020 |
_a0471407275 _cRM602.20 |
||
| 039 | 9 |
_a200310131044 _bafandi _c200309041206 _dafandi _c200305121501 _dzaleha _c200303220843 _dazlan _y11-05-2002 _zzaleha |
|
| 060 | _aQV771 | ||
| 090 | _aQV771.G123d 2002 | ||
| 100 | 1 |
_aGad, Shayne C., _d1948- |
|
| 245 | 1 | 0 |
_aDrug safety evaluation / _cShayne C. Gad |
| 260 |
_aNew York : _bJohn Wiley & Sons, _c2002 |
||
| 300 |
_axi, 1007 p. : _bill. ; _c24 cm. |
||
| 650 | 2 |
_aDrug Evaluation, Preclinical _zUnited States |
|
| 650 | 2 |
_aDrug Evaluation _zUnited States |
|
| 650 | 2 |
_aProduct Surveillance, Postmarketing _zUnited States |
|
| 907 |
_a.b13129855 _b2019-11-12 _c2019-11-12 |
||
| 942 |
_c01 _n0 _kQV771.G123d 2002 |
||
| 914 | _avtls000326096 | ||
| 990 | _azh | ||
| 991 | _aJabatan Farmasi, HUKM | ||
| 998 |
_ah _b2002-05-11 _cm _da _feng _gxxu _y0 _z.b13129855 |
||
| 999 |
_c312631 _d312631 |
||